KRSA · Korsana Biosciences Inc
United States · RS rating 96 · As of 2026-11-03
| Price | 31.96 USD |
|---|---|
| 1-day change | +0.9% |
| RS rating (overall / 1M / 3M / 12M) | 96 / 69 / 92 / 96 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 41 / 69 / 27 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +28.4% |
| Market cap (USD) | $1.6B |